PMC:7396557 / 28660-28815 JSONTXT

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T143","span":{"begin":35,"end":40},"obj":"UBERON:0001977"},{"id":"T144","span":{"begin":41,"end":43},"obj":"CHEBI:16480;CHEBI:16480"},{"id":"T145","span":{"begin":86,"end":105},"obj":"CHEBI:34018;CHEBI:34018"},{"id":"T146","span":{"begin":107,"end":109},"obj":"CHEBI:34018;CHEBI:34018"},{"id":"T147","span":{"begin":114,"end":120},"obj":"UBERON:0001969"},{"id":"T148","span":{"begin":134,"end":141},"obj":"UBERON:0001155"},{"id":"T76616","span":{"begin":35,"end":40},"obj":"UBERON:0001977"},{"id":"T69148","span":{"begin":41,"end":43},"obj":"CHEBI:16480;CHEBI:16480"},{"id":"T9725","span":{"begin":86,"end":105},"obj":"CHEBI:34018;CHEBI:34018"},{"id":"T41050","span":{"begin":107,"end":109},"obj":"CHEBI:34018;CHEBI:34018"},{"id":"T88140","span":{"begin":114,"end":120},"obj":"UBERON:0001969"},{"id":"T43443","span":{"begin":134,"end":141},"obj":"UBERON:0001155"}],"text":"Efficacy was mediated by improving serum NO levels and reducing the concentrations of 5-hydroxytryptamine (5-HT), plasma motilin, and colonic somatostatin."}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T177","span":{"begin":35,"end":40},"obj":"Body_part"},{"id":"T178","span":{"begin":86,"end":105},"obj":"Body_part"},{"id":"T179","span":{"begin":107,"end":111},"obj":"Body_part"},{"id":"T180","span":{"begin":114,"end":120},"obj":"Body_part"},{"id":"T181","span":{"begin":121,"end":128},"obj":"Body_part"},{"id":"T182","span":{"begin":142,"end":154},"obj":"Body_part"}],"attributes":[{"id":"A177","pred":"fma_id","subj":"T177","obj":"http://purl.org/sig/ont/fma/fma63083"},{"id":"A178","pred":"fma_id","subj":"T178","obj":"http://purl.org/sig/ont/fma/fma67245"},{"id":"A179","pred":"fma_id","subj":"T179","obj":"http://purl.org/sig/ont/fma/fma67245"},{"id":"A180","pred":"fma_id","subj":"T180","obj":"http://purl.org/sig/ont/fma/fma62970"},{"id":"A181","pred":"fma_id","subj":"T181","obj":"http://purl.org/sig/ont/fma/fma83368"},{"id":"A182","pred":"fma_id","subj":"T182","obj":"http://purl.org/sig/ont/fma/fma83349"}],"text":"Efficacy was mediated by improving serum NO levels and reducing the concentrations of 5-hydroxytryptamine (5-HT), plasma motilin, and colonic somatostatin."}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T78","span":{"begin":35,"end":40},"obj":"Body_part"}],"attributes":[{"id":"A78","pred":"uberon_id","subj":"T78","obj":"http://purl.obolibrary.org/obo/UBERON_0001977"}],"text":"Efficacy was mediated by improving serum NO levels and reducing the concentrations of 5-hydroxytryptamine (5-HT), plasma motilin, and colonic somatostatin."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T274","span":{"begin":109,"end":111},"obj":"http://purl.obolibrary.org/obo/CLO_0004265"},{"id":"T275","span":{"begin":114,"end":120},"obj":"http://purl.obolibrary.org/obo/UBERON_0001969"},{"id":"T276","span":{"begin":134,"end":141},"obj":"http://purl.obolibrary.org/obo/UBERON_0001155"}],"text":"Efficacy was mediated by improving serum NO levels and reducing the concentrations of 5-hydroxytryptamine (5-HT), plasma motilin, and colonic somatostatin."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T223","span":{"begin":107,"end":111},"obj":"Chemical"},{"id":"T224","span":{"begin":142,"end":154},"obj":"Chemical"}],"attributes":[{"id":"A223","pred":"chebi_id","subj":"T223","obj":"http://purl.obolibrary.org/obo/CHEBI_28790"},{"id":"A224","pred":"chebi_id","subj":"T224","obj":"http://purl.obolibrary.org/obo/CHEBI_64628"}],"text":"Efficacy was mediated by improving serum NO levels and reducing the concentrations of 5-hydroxytryptamine (5-HT), plasma motilin, and colonic somatostatin."}

{"project":"LitCovid-sentences","denotations":[{"id":"T224","span":{"begin":0,"end":155},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Efficacy was mediated by improving serum NO levels and reducing the concentrations of 5-hydroxytryptamine (5-HT), plasma motilin, and colonic somatostatin."}

{"project":"LitCovid-PubTator","denotations":[{"id":"774","span":{"begin":121,"end":128},"obj":"Gene"},{"id":"798","span":{"begin":86,"end":105},"obj":"Chemical"},{"id":"799","span":{"begin":107,"end":111},"obj":"Chemical"},{"id":"813","span":{"begin":134,"end":154},"obj":"Disease"}],"attributes":[{"id":"A774","pred":"tao:has_database_id","subj":"774","obj":"Gene:4295"},{"id":"A798","pred":"tao:has_database_id","subj":"798","obj":"MESH:D012701"},{"id":"A799","pred":"tao:has_database_id","subj":"799","obj":"MESH:D012701"},{"id":"A813","pred":"tao:has_database_id","subj":"813","obj":"MESH:D003110"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Efficacy was mediated by improving serum NO levels and reducing the concentrations of 5-hydroxytryptamine (5-HT), plasma motilin, and colonic somatostatin."}